Patent · US Active

Heterocyclic amides as kinase inhibitors

US10899716B2 · kind B2 · utility

1Cited by

6References

2Claims

0Family size

Assignee

GlaxoSmithKline Intellectual Property Development Limited · GB

Inventors

Niall Andrew Anderson · Stevenage, GB
Deepak Bandyopadhyay · King of Prussia, US
Alain Claude-Marie Daugan · Les Ulis, FR
Frederic G. Donche · Les Ulis, FR
Patrick M. Eidam · Collegeville, US
Nicolas Eric Faucher · Les Ulis, FR
Nicolas S. George · Les Ulis, FR
Philip Anthony Harris · Raleigh, US
Jae U. Jeong · Blue Bell, US
Bryan Wayne King · Blue Bell, US
Clark A. Sehon · King of Prussia, US
Gemma Victoria White · Stevenage, GB
David Wisnoski · Quakertown, US

Key dates

Filing date	Jan 31, 2020
Grant date	Jan 26, 2021
Priority date	—
Expiry date	Jan 31, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds having the formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.